ClearView clears key regulatory hurdle as APRA approves Zurich takeover
ClearView Wealth Limited (ASX: CVW) has received APRA Approval for the proposed acquisition of all ClearView Shares by Zurich Financial Services Australia Limited, clearing one of the final regulatory conditions ahead of an imminent shareholder vote.
The acquisition, structured as a members’ scheme of arrangement, was first announced on 24 February 2026 under a scheme implementation deed (SID) between ClearView and Zurich. The regulatory clearance marks a material step in a process now approaching its decisive phase.
With this approval secured, the Scheme Meeting is set for 10:00am (Sydney time), Monday 27 July 2026, where ClearView Shareholders will vote on the transaction.
The approval was granted under the Financial Sector (Shareholdings) Act 1998 (Cth) and satisfies the Condition Precedent described in Section 6.4(a)(viii) of the Scheme Booklet. For shareholders monitoring the deal’s progress, this represents one of the last major external hurdles before the transaction can proceed to implementation.
When big ASX news breaks, our subscribers know first
What the APRA Approval means for the deal timeline
Under the SID, implementation of the Scheme was conditional on approval by the Treasurer of the Commonwealth of Australia (or their delegate) of the proposed acquisition under the Financial Sector (Shareholdings) Act 1998 (Cth), a condition defined in the announcement as “APRA Approval.”
ACCC approval of the Zurich acquisition was secured earlier in the process, with Crescent Capital Partners, ClearView’s largest shareholder holding a 53.0% stake, already committed in writing to vote in favour of the Scheme ahead of the July meeting.
With this condition now satisfied, attention shifts to the remaining Conditions Precedent that must be met (or, where applicable, waived) before the Scheme can be implemented.
The outstanding conditions include:
-
ClearView Shareholder approval of the Scheme at the Scheme Meeting.
-
Final Court approval of the Scheme at the Second Court Hearing.
| Milestone | Date | Status | Reference |
|---|---|---|---|
| Scheme announced | 24 Feb 2026 | Complete | SID signed |
| Scheme Booklet despatched | 26 Jun 2026 | Complete | — |
| APRA Approval | 22 Jul 2026 | Received ✓ | Section 6.4(a)(viii) |
| Scheme Meeting | 27 Jul 2026 | Upcoming | Shareholder vote |
| Second Court Hearing | Pending | Outstanding | Final approval |
Directors’ recommendation and key voting dates
The ClearView Directors continue to unanimously recommend that shareholders vote in favour of the Scheme at the Scheme Meeting, in the absence of a Superior Proposal and subject to the Independent Expert continuing to conclude that the Scheme is in the best interests of ClearView Shareholders.
Each ClearView Director who holds or controls ClearView Shares at the time of the announcement intends to vote, or cause to be voted, all such shares in favour of the Scheme, subject to those same qualifications.
Directors’ recommendation
The ClearView Directors continue to unanimously recommend that ClearView Shareholders vote in favour of the Scheme at the Scheme Meeting, in the absence of a Superior Proposal and subject to the Independent Expert continuing to conclude that the Scheme is in the best interests of ClearView Shareholders.
Shareholders should note the following key dates and actions:
-
Proxy lodgement deadline: 10:00am (Sydney time), Saturday 25 July 2026.
-
Scheme Meeting: 10:00am (Sydney time), Monday 27 July 2026, held as a hybrid meeting.
-
Proxies can be appointed online at www.investorvote.com.au (SRN or HIN and Control Number required).
-
The Scheme Booklet was despatched on 26 June 2026 and shareholders are advised to read it carefully and in its entirety before making a voting decision.
The Scheme Booklet contains detailed information about the Scheme, including instructions on how to attend, vote at, and appoint a proxy for the Scheme Meeting.
What comes next for ClearView shareholders
The path to completion is now clearly defined. Shareholders will vote at the Scheme Meeting on 27 July 2026, after which the Scheme, if approved, will proceed to the Second Court Hearing for final approval. Only once these steps are satisfied can the Scheme move to implementation.
With the APRA Approval received, the remaining conditions, shareholder approval and Court sanction, represent the final stages of the process.
For shareholders, the reduced regulatory risk profile and defined sequence of remaining steps provide greater clarity on the deal’s trajectory. However, completion remains subject to the satisfaction of the outstanding Conditions Precedent, and the transaction should not be regarded as certain until all conditions are met.
Stay Ahead on ASX Finance and Fintech News
Get FREE breaking ASX announcements delivered to your inbox within minutes of release, complete with in-depth analysis already done for you. Over 20,000+ subscribers rely on Big News Blast to stay ahead of market-moving financial sector news. Click the “Free Alerts” button to start receiving alerts the moment they drop.